Related Experiment Video
Updated: Mar 30, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Early Predictors of Ten-Year Course in First-Episode Psychosis
Svein Friis1, Ingrid Melle1, Jan Olav Johannessen1
1Dr. Friis, Dr. Melle, and Dr. Røssberg are with the Division of Mental Health and Addiction, and Dr. Barder is with the Women and Children's Division, all at Oslo University Hospital, Oslo, Norway (e-mail: svein.friis@medisin.uio.no ). Dr. Friis, Dr. Melle, and Dr. Røssberg are also with the Institute of Clinical Medicine, University of Oslo, where Dr. Evensen and Dr. Opjordsmoen are affiliated. Dr. Evensen is also with the Adult Psychiatric Department Vinderen, Diakonhjemmet Hospitals, Oslo. Dr. Johannessen, Dr. ten Velden Hegelstad, Dr. Joa, Dr. Langeveld, and Dr. Larsen are with the Division of Psychiatry, Network of Clinical Psychosis Research, Stavanger University Hospital, Stavanger, Norway. Dr. Johannessen and Dr. Joa are also with the Faculty of Social Sciences, University of Stavanger. Dr. Larsen is also with the Psychiatry Section, Department of Clinical Medicine, University of Bergen, Bergen, Norway. Dr. Haahr is with the Early Psychosis Intervention Center, Psychiatry East-Region Zealand, Roskilde, Denmark. Dr. Haahr is also with the Faculty of Medical Sciences, Institute of Clinical Medicine, University of Copenhagen, Denmark, where Dr. Simonsen is affiliated. Dr. Simonsen is also with the Psychiatric Research Unit, Region Zealand, Roskilde, Denmark. Dr. Rund is with the Department of Psychology, University of Oslo, and with the Vestre Viken Hospital Trust, Drammen, Norway. Dr. Vaglum is with the Department of Behavioral Sciences in Medicine, University of Oslo. Dr. McGlashan is with the Department of Social and Behavioral Health, Yale School of Medicine, Yale University, New Haven, Connecticut.
Objective:
Identifying patients at risk of poor outcome at an early stage of illness can aid in treatment planning. This study sought to create a best-fit statistical model of known baseline and early-course risk factors to predict time in psychosis during a ten-year follow-up period after a first psychotic episode.
Methods:
Between 1997 and 2000, 301 patients with DSM-IV nonorganic, nonaffective first-episode psychosis were recruited consecutively from catchment area-based sectors in Norway and Denmark. Specialized mental health personnel evaluated patients at baseline, three months, and one, two, five, and ten years (N=186 at ten years). Time in psychosis was defined as time with scores ≥4 on any of the Positive and Negative Syndrome Scale items P1, P3, P5, P6, and G9. Evaluations were retrospective, based on clinical interviews and all available clinical information. During the first two years, patients were also evaluated by their clinicians at least biweekly. Baseline and early-course predictors of long-term course were identified with linear mixed-model analyses.
Results:
Four variables provided significant, additive predictions of longer time in psychosis during the ten-year follow-up: deterioration in premorbid social functioning, duration of untreated psychosis (DUP) of ≥26 weeks, core schizophrenia spectrum disorder, and no remission within three months.
Conclusions:
First-episode psychosis patients should be followed carefully after the start of treatment. If symptoms do not remit within three months with adequate treatment, there is a considerable risk of a poor long-term outcome, particularly for patients with a deterioration in premorbid social functioning, a DUP of at least half a year, and a diagnosis within the core schizophrenia spectrum.
More Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...